Q5137 Injection, wezlana, sub cu, 1 milligrams
Also known as: Wezlana subcutaneous, anifrolumab-fnia
Injection of Wezlana, anifrolumab-fnia biosimilar subcutaneous per 1 milligram, for systemic lupus erythematosus.
In Plain Language
lupus treatment injection; immune system modulator
Clinical Context
Used for active lupus nephritis and systemic lupus erythematosus in adults.
RVU Information
CPT Q5137 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5137?
CPT Q5137 (Injection, wezlana, sub cu, 1 milligrams) is a Q Codes code. Injection of Wezlana, anifrolumab-fnia biosimilar subcutaneous per 1 milligram, for systemic lupus erythematosus.
Is Q5137 covered by insurance?
Q5137 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for active lupus nephritis and systemic lupus erythematosus in adults.
When is CPT Q5137 used?
Used for active lupus nephritis and systemic lupus erythematosus in adults.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.